// App-Quantinova.ai

e19354 : Real-world healthcare resource utilization (HRU)/costs associated with venetoclax treatment among chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients.

Researchers

Presenter

  • Kerry Anne Rogers

Principal Investigators

  • Bruno Emond

  • Ameur M Manceur

  • Frederic Kinkead

  • Marie-Hlne Lafeuille

  • Patrick Lefebvre

  • Qing Huang

Medical Centers

  • The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • Analysis Group, Inc., Montreal, QC, Canada

  • Janssen Scientific Affairs, Horsham, PA

Locations

  • United States

  • Canada

Companies

  • Analysis Group, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Venetoclax

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved